Epigenetic Market: Trends, Opportunities and Competitive Analysis [2023-2028]

Epigenetic Market Trends and Forecast

The future of the global epigenetic market looks promising with opportunities in the academic and research institutes, pharmaceutical companies and biotechnology companies, and contract research organizations (CROs). The global epigenetic market is expected to reach an estimated $3.6 billion by 2028 with a CAGR of 14.5% from 2023 to 2028. The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.

A more than 150-page report is developed to help in your business decisions.

Epigenetic Market by Segment

The study includes trends and forecast for the global epigenetic market by product & service, technology, end use industry, and region as follows:

Epigenetic Market by Product & Service [Shipment Analysis by Value from 2017 to 2028]:

• Kits & Reagents
• Enzymes
• Instruments & Accessories
• Software
• Services

Epigenetic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• DNA Methylation
• Histone Methylation
• Others

Epigenetic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Academic and Research Institutes
• Pharmaceutical Companies and Biotechnology Companies
• Contract Research Organizations (CROs)
• Others

Epigenetic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Epigenetic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, epigenetic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the epigenetic companies profiled in this report include:

• Abcam
• Active Motiff
• Hologic
• F. Hoffmann-La Roche
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Novartis
• Element Biosciences
• Dovetail Genomics

Epigenetic Market Insights

• Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Within this market, academics and research institutes will remain the largest end use segment due to the widespread adoption of epigenetic products across government research institutions and university laboratories.
• North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures, and the existence of major companies in this region.

Features of the Global Epigenetic Market

• Market Size Estimates: Epigenetic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
• Segmentation Analysis: Epigenetic market size by various segments, such as by product & service, technology, end use industry, and region in terms of value ($B).
• Regional Analysis: Epigenetic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different products & services, technologies, end use industries, and regions for the epigenetic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the Epigenetic Market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q.1. What is the epigenetic market size?
• Answer: The global epigenetic market is expected to reach an estimated $3.6 billion by 2028.
• Q.2. What is the growth forecast for epigenetic market?
• Answer: The global epigenetic market is expected to grow with a CAGR of 14.5% from 2023 to 2028
• Q.3. What are the major drivers influencing the growth of the epigenetic market?
• Answer: The major drivers for this market are enhanced commitment to epigenetic research and development through increased investment, funding, and approvals, growing application of epigenetics in advancing drug discovery and development, and broadening access to genome sequencing owing to its affordability and accessibility.
• Q4. What are the major segments for epigenetic market?
• Answer: The future of the global epigenetic market looks promising with opportunities in academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).
• Q5. Who are the key epigenetic companies?
• Answer: Some of the key epigenetic companies are as follows:
  • Abcam
  • Active Motiff
  • Hologic
  • F. Hoffmann-La Roche
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Novartis
  • Element Biosciences
  • Dovetail Genomics
• Q6. Which epigenetic market segment will be the largest in future?
• Answer: Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growing demand for simple-to-use, cost-effective, and advanced epigenetic kits and reagents across the globe.
• Q7. In epigenetic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to increasing awareness of advanced medical infrastructure, growing R&D expenditures and the existence of major companies in this region.
• Q.8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global epigenetic market by product & service (kits & reagents, enzymes, instruments & accessories, software, and services), technology (DNA methylation, histone methylation, and others), end use industry (academic and research institutes, pharmaceutical companies and biotechnology companies, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?